• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of all recall classifications meeting 26 calendar-day timeframe in the month

Dictionary: A recall is an effective method of removing or correcting consumer products that are in violation of laws administered by the Food and Drug Administration. A recall is a voluntary action that takes place to protect the public’s health and well-being from products that present a risk of injury or gross deception or are otherwise defective. A Class I recall is the most significant type of recall. A recall may be done for a single product dosage form or for multiple dosage forms, or multiple products.

Information is current as of September 30, 2014.

Fiscal Year - 2014

Skip graphic and jump to text data

TimeTargetPercentage
Oct 20138591
Nov 20138586
Dec 20138583
Jan 20148577
Feb 20148581
Mar 20148596
Apr 201485100
May 201485100
Jun 20148595
Jul 20148594
Aug 20148597
Sep 20148593

FY 2014 Overall: 91%

Footnotes

  • CDER created new measures and began collecting data in July 2012. Therefore, FY12 will only include 3 months of data.

Percentage of Class I classifications meeting 26 calendar-day timeframe in the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetPercentage
Oct 201390N/A
Nov 201390100
Dec 201390100
Jan 201490100
Feb 201490N/A
Mar 201490100
Apr 201490100
May 201490100
Jun 201490100
Jul 201490100
Aug 201490100
Sep 201490100

FY 2014 Overall: 100%

Percentage of Class II classifications meeting 26 calendar-day timeframe in the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetPercentage
Oct 20138588
Nov 20138588
Dec 20138572
Jan 20148572
Feb 20148583
Mar 201485100
Apr 201485100
May 201485100
Jun 20148592
Jul 20148591
Aug 201485100
Sep 20148593

FY 2014 Overall: 89%

Percentage of Class III classifications meeting 26 calendar-day timeframe in the month

Fiscal Year - 2014
Skip graphic and jump to text data.

TimeTargetPercentage
Oct 201380100
Nov 20138075
Dec 20138089
Jan 20148067
Feb 20148075
Mar 20148083
Apr 201480100
May 201480100
Jun 201480100
Jul 201480100
Aug 20148089
Sep 20148083

FY 2014 Overall: 89%

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.